BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33729700)

  • 41. Pancreatic cancer: challenges and opportunities.
    Zhu H; Li T; Du Y; Li M
    BMC Med; 2018 Nov; 16(1):214. PubMed ID: 30463539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exosomes and the Future of Immunotherapy in Pancreatic Cancer.
    Batista IA; Melo SA
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy and Prevention of Pancreatic Cancer.
    Morrison AH; Byrne KT; Vonderheide RH
    Trends Cancer; 2018 Jun; 4(6):418-428. PubMed ID: 29860986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combinational therapy: new hope for pancreatic cancer?
    Shi S; Yao W; Xu J; Long J; Liu C; Yu X
    Cancer Lett; 2012 Apr; 317(2):127-35. PubMed ID: 22138436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Curing pancreatic cancer.
    Traub B; Link KH; Kornmann M
    Semin Cancer Biol; 2021 Nov; 76():232-246. PubMed ID: 34062264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects].
    Ye C; Zheng L; Yuan CH
    Zhonghua Wai Ke Za Zhi; 2019 Jan; 57(1):10-15. PubMed ID: 30612387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.
    Baines AT; Martin PM; Rorie CJ
    Prog Mol Biol Transl Sci; 2016; 144():277-320. PubMed ID: 27865460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgery for pancreatic cancer: recent controversies and current practice.
    Wray CJ; Ahmad SA; Matthews JB; Lowy AM
    Gastroenterology; 2005 May; 128(6):1626-41. PubMed ID: 15887155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of pancreatic cancer: challenge of the facts.
    Beger HG; Rau B; Gansauge F; Poch B; Link KH
    World J Surg; 2003 Oct; 27(10):1075-84. PubMed ID: 12925907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunologic approaches to the management of pancreatic cancer.
    Laheru D; Biedrzycki B; Jaffee EM
    Cancer J; 2001; 7(4):324-37. PubMed ID: 11561608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Advances in immunotherapy of pancreatic ductal adenocarcinoma].
    Yang JQ; Wei T; Chen YW; Bai XL; Liang TB
    Zhonghua Wai Ke Za Zhi; 2017 May; 55(5):396-400. PubMed ID: 28464583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The safety and efficacy of chemotherapy combined with immunotherapy for pancreatic cancer: A meta-analysis.
    Huang Y; Yan X; Ren T; Yi F; Li Q; Zhang C
    Medicine (Baltimore); 2021 Jul; 100(29):e26673. PubMed ID: 34398033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapy and Combination Strategies in Pancreatic Cancer: Current Status and Emerging Trends.
    Cheung PF; Lutz M; Siveke JT
    Oncol Res Treat; 2018; 41(5):286-290. PubMed ID: 29705789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging and Management of Pancreatic Cancer.
    Kobi M; Veillette G; Narurkar R; Sadowsky D; Paroder V; Shilagani C; Gilet A; Flusberg M
    Semin Ultrasound CT MR; 2020 Apr; 41(2):139-151. PubMed ID: 32446428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospects of targeted and immune therapies in SCLC.
    Hendriks LEL; Menis J; Reck M
    Expert Rev Anticancer Ther; 2019 Feb; 19(2):151-167. PubMed ID: 30590971
    [No Abstract]   [Full Text] [Related]  

  • 56. Research progress on circularRNAs in pancreatic cancer: emerging but promising.
    Wang YZ; An Y; Li BQ; Lu J; Guo JC
    Cancer Biol Ther; 2019; 20(9):1163-1171. PubMed ID: 31138014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene and cell therapy for pancreatic cancer.
    Singh HM; Ungerechts G; Tsimberidou AM
    Expert Opin Biol Ther; 2015 Apr; 15(4):505-16. PubMed ID: 25582170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy.
    Torphy RJ; Schulick RD; Zhu Y
    Mol Carcinog; 2020 Jul; 59(7):775-782. PubMed ID: 32166821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Multidisciplinary therapy for pancreatic cancer - clinical impact for preoperative therapy and peptide vaccine therapy].
    Tani M; Yamaue H
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):364-7. PubMed ID: 22421762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directions.
    Antoniou G; Kountourakis P; Papadimitriou K; Vassiliou V; Papamichael D
    Cancer Treat Rev; 2014 Feb; 40(1):78-85. PubMed ID: 23810287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.